UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report

<!DOCTYPE html> <html lang="en"> <head> <meta charset="UTF-8"> <title> UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report </title> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <link rel="canonical" href="https://www.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/" />  <script async src="https://www.googletagmanager.com/gtag/js?id=G-YK7FCK71TD"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-YK7FCK71TD'); </script> <meta name="description" content="" /> <meta name="keywords" content="" />  <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:title" content="UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report"> <meta name="twitter:description" content=""> <meta name="twitter:image" content="https://www.biopharmatrend.com/files/blog/social/iStock-518622281.jpg">  <meta property="og:type" content="article" /> <meta property="og:url" content="https://www.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/" /> <meta property="og:title" content="UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report" /> <meta property="og:description" content="" /> <meta property="article:published_time" content="2024-11-06T11:25:42+00:00"> <meta property="article:modified_time" content="2024-11-06T11:25:42+00:00"> <meta name="author" content="Roman Kasianov"> <meta property="og:image" content="https://www.biopharmatrend.com/files/blog/social/iStock-518622281.jpg"> <script type="application/ld+json">{ "@context": "https://schema.org", "@type": "NewsArticle", "headline": "UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report", "datePublished": "2024-11-06T11:25:42+00:00", "dateModified": "2024-11-06T11:25:42+00:00", "description": "New research from the\nBritish Business Bank\nreveals that life sciences venture capital (VC) funds are delivering higher realized returns for investors compared to the overall market. According to the \"UK Venture Capital Financial Returns 2024\" report, life sciences funds across the UK, US, and Europe with vintages from 2002 to 2019 reported a pooled\nDistributions to Paid-In capital (DPI)\nmultiple of\n1.14\n, surpassing the overall market figure of\n1.02\n.\nDPI\nis a financial metric that measures the cash or stock distributions to investors relative to the capital they have invested.", "image": "https://www.biopharmatrend.com/files/blog/social/iStock-518622281.jpg", "url": "https://www.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/" }, "publisher": { "@type": "Organization", "name": "BiopharmaTrend", "url": "https://www.biopharmatrend.com", "logo": { "@type": "ImageObject", "url": "https://www.biopharmatrend.com/static/img/bpt_logo.png" } }, "author": [ { "@type": "Person", "name": "Roman Kasianov", "url": "https://www.biopharmatrend.com/contributor/743/" } ] }</script> <style type="text/css"> .ap-chart-load svg { width: 100%; } .post-meta .author-linkein-icon { width: 1em; vertical-align: baseline; } .text-miniblock { display: inline-block; box-shadow: 0 0 6px -1px forestgreen; background: white; padding: 0.5rem; } .post .text-miniblock a { color: black; } .post .text-miniblock a:hover, .post .text-miniblock a:active { color: #333; text-decoration: underline; } .text-miniblock-right { float: right; margin: 0 0 1rem 1rem; max-width: 14rem; } .subscribe-block { background-color: deepskyblue; color: white; margin-top: 1.5rem; margin-bottom: 2rem; padding-top: 1.5rem; padding-bottom: 1.5rem; width: calc(50% + 100vw); padding-left: calc(50vw - 50%); padding-right: 50vw; margin-left: calc(50% - 50vw); position: relative; } .subscribe-block > .subscribe-inner { background-image: url('/files/subscription-bg.png'); background-position: right bottom; background-size: auto 120%; background-repeat: no-repeat; } .mobile-only { display: none; } @media screen and (max-width: 34em) { .text-miniblock-right { float: none; margin: 1rem 0; max-width: 100%; } .subscribe-block > .subscribe-inner { background-image: unset; } .mobile-only { display: block; } } </style> <link rel="shortcut icon" href="/static/favicon.ab1145f4d518.ico" /> <link rel="stylesheet" type="text/css" href="/static/css/main.6dead4e2266d.css" /> </head> <body> <div id="main-preheader"> <div class="container block-preheader"> <div id="logo-top"> <a href="/"><b>BioPharmaTrend</b></a>  </div> <div class="burger-container"> <div class="burger-button-container"> <button type="button" class="burger-button" onclick="document.documentElement.classList.toggle('blockfix');this.parentElement.parentElement.classList.toggle('active');"> <div class="burger-line burger-line-1"></div> <div class="burger-line burger-line-2"></div> <div class="burger-line burger-line-3"></div> </button> </div>  <div id="main-search-menu"> <div class="top-search"> <form action="/search/" class="top-search-form"> <button type="submit" class="btn btn-default"><i class="glyphicon glyphicon-search"></i></button> <input type="text" name="q" value="" size="10" class="form-control form-control-inline" required="" placeholder="e.g. 'quantum tech' or 'stem cell'"> <input type="hidden" name="section" value="insights"> </form> <span class="top-search-switcher button" onclick="this.parentElement.classList.toggle('active')"> <span class="glyphicon glyphicon-search"></span> <span class="glyphicon glyphicon-remove"></span> </span> </div> <span class="top-search-switcher button"> <span class="glyphicon glyphicon-search"></span> </span> </div>  <nav id="main-menu"> <div class="mobile-menu-item"> <a class="top-menu-link mobile-menu-item-title" href="/section/news/"><b>Latest News</b></a> </div> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">All Topics <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <li><a class="top-menu-link" href="/topic/bioeconomy-society/">Bioeconomy & Society</a></li> <li><a class="top-menu-link" href="/topic/ai-digital/">AI & Digital</a></li> <li><a class="top-menu-link" href="/topic/startups/">Startups & Deals</a></li> <li><a class="top-menu-link" href="/topic/neurotech/">NeuroTech</a></li> <li><a class="top-menu-link" href="/topic/clinical-trials/">Clinical Trials</a></li> <li><a class="top-menu-link" href="/topic/synbio/">Biotech</a></li> <li><a class="top-menu-link" href="/topic/tools-methods/">Tools & Methods</a></li> <li><a class="top-menu-link" href="/topic/healthtech/">HealthTech</a></li> <li><a class="top-menu-link" href="/topic/aging-research/">Aging & Longevity</a></li> <li><a class="top-menu-link" href="/topic/contract-research/">Contract Research</a></li> <div class="sub-menu-margin"></div>  <li><a class="top-menu-link" href="/section/latest/">Latest insights</a></li> <li><a class="top-menu-link" href="/premium-content/">Premium Content</a></li> <div class="sub-menu-margin" style="border-bottom: 1px solid limegreen;"></div> <li><a class="top-menu-link" href="/knowledge-center/">Knowledge Center</a></li> </ul> </div> </div> <div class="mobile-menu-item"> <a class="top-menu-link mobile-menu-item-title" href="/section/interviews/"><b>Interviews</b></a> </div>  <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">Companies <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu">  <li><a class="top-menu-link" href="/m/marketplace/">Company Directory</a></li> <li><a class="top-menu-link" href="/section/interviews/">Interviews with Thought Leaders</a></li> <li><a class="top-menu-link" href="/section/case-studies/">Sponsored Case Studies</a></li> <li><a class="top-menu-link" href="/m/editor-tool/">Create Company Profile</a></li> </ul> </div> </div> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">More <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <li><a class="top-menu-link" href="/about/">About Us</a></li> <li><a class="top-menu-link" href="/about/team/">Our Team</a></li> <li><a class="top-menu-link" href="/about/advisory-board/">Advisory Board</a></li> <li><a class="top-menu-link" href="/about/press-citations/">Citations and Press Coverage</a></li> <li><a class="top-menu-link" href="/events/">Partner Events Calendar</a></li> <li><a class="top-menu-link" href="/advertising-media-kit/">Advertise with Us</a></li> <li><a class="top-menu-link" href="/contributor/">Write for Us</a></li> </ul> </div> </div> </nav> </div> <div id="main-user-actions">  <div class="mobile-menu-item"> <a href="/membership/" class="button-subscribe top-menu-link">Subscribe</a> </div>  <div class="mobile-menu-item last"> <a href="#" class="mobile-menu-item-title" rel="nofollow" title="Login/Join" onclick="document.getElementById('login-popup').classList.toggle('hidden')"> <span class="glyphicon glyphicon-log-in"></span> <span class="mobile-hide-m">Login/Join</span> </a> </div> </div> </div> </div> <div id="main-preheader-margin"></div> <div id="sencondary-menu-block"> <div class="container clearfix"> <nav> <ul class="text-center"> <li><a href="/topic/ai-digital/">AI & Digital</a></li> <li><a href="/topic/startups/">Startups & Deals</a></li> <li><a href="/topic/neurotech/">NeuroTech</a></li> <li><a href="/topic/clinical-trials/">Clinical Trials</a></li> <li><a href="/topic/synbio/">Biotech</a></li> <li><a href="/topic/tools-methods/">Tools & Methods</a></li> </ul> </nav> </div> </div>  <div id="main-content" class="container"> <main id="content" class="col-lg-9 col-md-8 col-sm-12 col-xs-12"> <div class="mobile-only"> </div> <article id="post-1012" class="post "> <header> <h1>UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report</h1> </header> <footer class="post-meta"> <div class="tooltip"> <span class="glyphicon glyphicon-pencil"></span> by <a href="/contributor/743/">Roman Kasianov</a> </span>    <span style="white-space: nowrap;"> <span class="glyphicon glyphicon-folder-open"></span>   News </span> <div class="tooltip-text"> <div class="tooltip-close" onclick="this.parentElement.parentElement.classList.toggle('tooltip-show');"></div> <p><b>Disclaimer</b>: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. <br> Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.</p> </div> </div> <div> <span class="glyphicon glyphicon-calendar" title="Published on"></span> <time datetime="2024-11-06">Nov. 6, 2024</time>    </em> </div> <div class="tags"> <b>Topics: </b> <a href="/topic/startups/">Startups & Deals</a>    </div> <div> <strong>Share: </strong>   <a target="_blank" rel="nofollow" href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/"> <img alt="Share in LinkedIn" src="/static/img/soc-in.7bc286fd757e.png" width="28" height="28"></a>  <a target="_blank" rel="nofollow" href="https://www.reddit.com/submit?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/"> <img alt="Share in Reddit" src="/static/img/soc-reddit.342e87a07115.png" width="28" height="28"></a>  <a target="_blank" rel="nofollow" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/"> <img alt="Share in X" src="/static/img/soc-x.3c80e8291cba.png" width="28" height="28"></a>  <a target="_blank" rel="nofollow" href="https://news.ycombinator.com/submitlink?u=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/"> <img alt="Share in Hacker News" src="/static/img/soc-y.587f16a5f3f3.png" width="28" height="28"></a>  <a target="_blank" rel="nofollow" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/&display=page"> <img alt="Share in Facebook" src="/static/img/soc-fb.3031a5a810f0.png" width="28" height="28" /></a>  <a target="_blank" rel="nofollow" href="mailto:?subject=Biopharmatrend.com&body=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/"> <img alt="Send by email" src="/static/img/soc-mail.41ce3608f438.png" width="28" height="28"></a>   |  <a href="/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/pdf/" target="_blank" rel="nofollow"> <span style="vertical-align: text-top; color: deepskyblue; font-size: 1.5em;" class="glyphicon glyphicon-print"></span></a> </div> </footer> <section> <div class="flex max-w-full flex-col flex-grow"> <div class="min-h-8 text-message flex w-full flex-col items-end gap-2 whitespace-normal break-words [.text-message+&]:mt-5" data-message-author-role="assistant" data-message-id="bde9a657-b8c6-4c0a-8941-c8e964117d7f" data-message-model-slug="gpt-4o" dir="auto"> <div class="flex w-full flex-col gap-1 empty:hidden first:pt-[3px]"> <div class="markdown prose w-full break-words dark:prose-invert dark"> <p>New research from the <a href="http://www.british-business-bank.co.uk/">British Business Bank</a> reveals that life sciences venture capital (VC) funds are delivering higher realized returns for investors compared to the overall market. According to the "UK Venture Capital Financial Returns 2024" report, life sciences funds across the UK, US, and Europe with vintages from 2002 to 2019 reported a pooled <strong>Distributions to Paid-In capital (DPI)</strong> multiple of <strong>1.14</strong>, surpassing the overall market figure of <strong>1.02</strong>. <strong>DPI</strong> is a financial metric that measures the cash or stock distributions to investors relative to the capital they have invested.</p> </div> </div> </div> </div> <p>While the <strong>Total Value to Paid-In capital (TVPI)</strong> multiple for life sciences funds was <strong>1.76</strong>, slightly below the wider market multiple of <strong>1.99</strong>, this is attributed to the sector's nature. <strong>TVPI</strong> assesses both realized returns and the current value of unrealized investments relative to the capital invested. In the life sciences sector, companies often need to achieve significant milestones—such as successful clinical trials—before their valuations see substantial increases.</p> <h4>Green Tech Investments Show Increased Commercial Viability</h4> <p>The green technology sector has rebounded since its downturn in 2010. For funds with vintages from 2014 to 2022, green tech funds produced a pooled TVPI multiple of <strong>1.55</strong>, aligning more closely with the wider market multiple of <strong>1.64</strong>. This improvement suggests that the second wave of green tech innovation is producing more commercially viable propositions, leading to increased valuations and investor confidence.</p> <h4>UK VC Returns Competitive with US and Europe</h4> <p>Historically perceived as lower, UK VC returns have matched or exceeded those in the US and Europe for older vintages. For funds established between 2002 and 2019, UK VC funds generated a pooled TVPI multiple of <strong>1.87</strong>, compared to <strong>2.01</strong> for US funds and <strong>1.96</strong> for European funds. Specifically, UK funds from the 2002-2007 vintages outperformed both regions on DPI and TVPI measures.</p> <p>For more recent vintages (2014-2022), UK funds have a pooled return of <strong>1.64</strong>, which is in line with the US (<strong>1.63</strong>) but slightly below Europe (<strong>1.76</strong>), reflecting current market challenges and portfolio valuations being marked down.</p> <blockquote> <p>See also: <a href="https://www.biopharmatrend.com/post/632-breaking-through-the-investment-gap-mark-andrews-discusses-british-patient-capitals-life-sciences-fund/">Breaking Through the Investment Gap: Mark Andrews Discusses British Patient Capital's Life Sciences Fund</a></p> </blockquote> <h4>Valuations Decline Slightly in 2023/24, Mirroring Global Trends</h4> <p>In an analysis of 139 UK funds reporting data in both 2023 and 2024, the UK's pooled DPI remained steady at <strong>0.37</strong>, similar to last year's figure of <strong>0.36</strong>. This suggests that a lack of exit opportunities remains a key challenge for fund managers. The pooled TVPI multiple decreased from <strong>1.73</strong> to <strong>1.61</strong>, indicating that fund managers continue to adjust portfolio valuations downward. This trend is consistent with declines in Europe (from <strong>1.87</strong> to <strong>1.75</strong>) and the US (from <strong>1.82</strong> to <strong>1.66</strong>), although UK funds were slightly more resilient than those in the US.</p> <p>Matt Adey, Senior Director of Economics at the British Business Bank, said: “This year’s report finds that the UK market continues to generate similar returns to the US and rest of Europe on some measures, while also slightly underperforming on others. While our survey results show that the majority of fund managers believe that fundraising conditions are challenging, it is encouraging that they are also expecting exit opportunities to improve over the next year.”</p> <h4>Fundraising Challenges Persist, Yet Optimism for Exits Grows</h4> <p>A survey of 42 UK VC fund managers found that <strong>69%</strong> reported the current state of the market for raising funds as poor or very poor, up from <strong>64%</strong> last year. These challenging conditions have led <strong>25%</strong> of general partners (GPs) to postpone plans for raising new funds.</p> <p>Despite these hurdles, fund managers are increasingly optimistic about exit opportunities—the ability to sell investments at a profit. While <strong>62%</strong> of fund managers still believe the availability of exit opportunities is poor or very poor—a <strong>10% decrease</strong> from 2023—nearly <strong>75%</strong> expect exit conditions to improve over the next year, with none expecting them to worsen.</p> <h4>British Patient Capital-Backed Funds Show Improved Performance</h4> <p>Funds backed by the British Business Bank's Enterprise Capital Funds (ECF) program have generally outperformed the wider UK market. ECF funds with vintages from 2006 to 2022 reported a pooled DPI of <strong>0.60</strong>. Due to the program's structure, where the Bank receives a lower share of potential profits, the DPI for other limited partners (LPs) in these funds was higher at <strong>0.70</strong>. Both figures exceed the wider market's pooled DPI of <strong>0.43</strong>.</p> <p>British Patient Capital (BPC)-backed funds with vintages from 2013 to 2022 reported a pooled DPI multiple of <strong>0.20</strong>, aligning with the wider market (<strong>0.19</strong>). When including unrealized investments, BPC funds' pooled TVPI of <strong>1.40</strong> is lower than the overall UK VC market's <strong>1.65</strong>, though the gap has narrowed from <strong>0.29</strong> in last year's report. The median TVPI multiple is now higher for BPC-supported funds (<strong>1.33</strong>) compared to the overall market (<strong>1.28</strong>), indicating an improvement in BPC's relative performance over the past year.</p> <h4>Industry Leaders Highlight the Importance of VC Investment</h4> <p>Michael Moore, Chief Executive of the British Private Equity and Venture Capital Association (BVCA), said:</p> <blockquote> <p><em>“The British Business Bank's report demonstrates the vital role that venture capital plays in the UK economy. This report shows how challenging it can be for venture capital firms to raise funds—currently, just 3% of worldwide pensions investment into UK-led growth equity and venture capital is from UK pension funds. This emphasizes the importance of initiatives linked to the pensions investment review which aim to catalyse institutional investment into UK venture capital and growth funds, and the businesses they invest in.”</em></p> </blockquote> <p>According to the report there's strong performance of UK life sciences and green tech VC funds in delivering returns to investors. Despite current fundraising challenges, the UK venture capital industry remains competitive with the US and Europe. Fund managers are cautiously optimistic about improved exit opportunities in the coming year, signaling potential growth and stability in the sector.</p> <div class="product-list"> </div> <p> <b>Topics: </b> <a href="/topic/startups/">Startups & Deals</a>    </p> </section> </article> <div style="margin: 1em 0 2em; padding: 0.5em 0;"> <strong>Share: </strong>   <a target="_blank" rel="nofollow" href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/"> <img alt="Share in LinkedIn" src="/static/img/soc-in.7bc286fd757e.png" width="28" height="28"></a>  <a target="_blank" rel="nofollow" href="https://www.reddit.com/submit?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/"> <img alt="Share in Reddit" src="/static/img/soc-reddit.342e87a07115.png" width="28" height="28"></a>  <a target="_blank" rel="nofollow" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/"> <img alt="Share in X" src="/static/img/soc-x.3c80e8291cba.png" width="28" height="28"></a>  <a target="_blank" rel="nofollow" href="https://news.ycombinator.com/submitlink?u=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/"> <img alt="Share in Hacker News" src="/static/img/soc-y.587f16a5f3f3.png" width="28" height="28"></a>  <a target="_blank" rel="nofollow" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/&display=page"> <img alt="Share in Facebook" src="/static/img/soc-fb.3031a5a810f0.png" width="28" height="28" /></a>  <a target="_blank" rel="nofollow" href="mailto:?subject=Biopharmatrend.com&body=https%3A%2F%2Fwww.biopharmatrend.com/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/"> <img alt="Send by email" src="/static/img/soc-mail.41ce3608f438.png" width="28" height="28"></a> </div> <div class="subscribe-block"> <div class="subscribe-inner"> <h3 style="line-height:1.5; font-weight: 900;"> <span style="font-weight: 900">Get Exclusive Insights Into Your Inbox</span> <br> <span style="font-weight: normal;">join 7000+ BPT insiders</span> </h3> <br> <div> <a style="font-size: 1.25em;width:17em; text-align: center; border-color: white; color: white; font-weight: 900" href="#" onclick="toggleMailingPopup(true)" class="btn">Subscribe</a> </div> </div> </div> </main> <aside id="main-sidebar" class="col-lg-3 col-md-4 col-sm-12 col-xs-12"> <section class="well"> <h4>Latest Articles</h4> <ul> <li><a href="/post/1029-novartis-expands-radiopharmaceutical-portfolio-with-745m-deal-with-ratio-therapeutics/">Novartis Expands Radiopharmaceutical Portfolio with $745M Deal with Ratio Therapeutics</a></li> <li><a href="/post/1024-immunai-and-teva-collaborate-to-advance-clinical-trials-in-oncology-and-immunology/">Immunai and Teva Collaborate to Advance Clinical Trials in Oncology and Immunology</a></li> <li><a href="/post/1022-genesis-therapeutics-collaborates-with-nvidia-and-secures-additional-nventures-funding-to-accelerate-ai-driven-drug-discovery/">Genesis Therapeutics Collaborates with NVIDIA and Secures Additional NVentures Funding to Accelerate AI-Driven Drug Discovery</a></li> <li><a href="/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/">Schr枚dinger and Novartis Forge Partnership to Scale Computational Drug Discovery</a></li> <li><a href="/post/1016-tempus-ai-to-acquire-ambry-genetics-for-600-million/">Tempus AI to Acquire Ambry Genetics for $600 Million</a></li> <li><a href="/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/">UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report</a></li> </ul> </section> </aside> </div> <footer id="main-footer"><div class="container"> <div class="row"> <div class="col-12 col-sm-6 col-lg-3"> <h4 class="footer-logo"><span style="font-weight: 900">BiopharmaTrend</span>.com</h4> <div style="margin-bottom: 1.25em" class="footer-logo-slogan">Where Tech Meets Bio</div>  <div style="margin-bottom: 0.5em;"><a href="#main-footer" onclick="toggleMailingPopup(true)" style="color: lemonchiffon"> <img src="/static/img/sm-mail.a3210e82fe37.png" alt="mail" width="32" height="32" />  <b>Newsletter</b> </a></div> <div style="margin-bottom: 0.5em"><a href="https://www.linkedin.com/company/biopharmatrend-com/" rel="nofollow" target="_blank"> <img src="/static/img/sm-in.fb9ea368635d.png" alt="in" width="32" height="32" />  LinkedIn </a></div> <div style="margin-bottom: 0.5em"><a href="https://twitter.com/BiopharmaTrend" rel="nofollow" target="_blank"> <img src="/static/img/sm-x.9f3327271e1a.png" alt="x" width="32" height="32" />  X </a></div> <div style="margin-bottom: 0.5em"><a href="https://news.google.com/publications/CAAqBwgKMOaRugsw86zRAw?hl=en-US&gl=US&ceid=US:en" rel="nofollow" target="_blank"> <img src="/static/img/sm-gnews.ac9eb4674c84.png" alt="gnews" width="32" height="32" />  Google News </a></div> <div><a href="/rss/" rel="nofollow" target="_blank"> <img src="/static/img/sm-rss.bcd2cefd2eba.png" alt="rss" width="32" height="32" />  RSS Feed </a></div> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>About</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/about/">What we do</a></li> <li><a href="/editorial-calendar/">Editorial Calendar</a></li> <li><a href="/about/press-citations/">Citations and Press Coverage</a></li> <li><a href="/terms-of-use/">Terms of Use</a></li> <li><a href="/privacy-policy/">Privacy Policy</a></li>  <li><a href="/about/disclaimer/">Disclaimer</a></li> </ul> </nav> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>We Offer</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/premium-content/"><b style="color: lemonchiffon">Premium Content</b></a></li> <li><a href="/m/marketplace/">BioTech Scout</a></li> <li><a href="/our-products/">Reports</a></li> <li><a href="/section/interviews/">Interviews</a></li> <li><a href="/events/">Partner Events</a></li> <li><a href="/section/case-studies/">Case Studies</a></li> </ul> </nav> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>Opportunities</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/membership/">Membership</a></li> <li><a href="/advertising-media-kit/">Advertise</a></li> <li><a href="/m/editor-tool/">Submit Company</a></li> <li><a href="/contributor/">Write for Us</a></li> <li><a href="/guest-blog/guidelines/">Author Guidelines</a></li> <li><a href="/a/contact/">Contact Us</a></li> </ul> </nav> </div> </div> <hr> <div class="text-right">© BPT Analytics LTD 2024</div> </div></footer> <div id="bpt-consent"><div class="container"> <div class="row"> <div class="col-12 col-md-6 col-lg-8"> We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our <a href="/cookies-policy/">cookies policy</a>. </div> <div class="col-12 col-md-6 col-lg-4 text-right"> <button class="btn btn-primary btn-sm" type="button" onclick="changeConsent('analytics')" style="white-space:unset">Agree</button> </div> </div> </div></div> <div id="login-popup" class="hidden popup"> <div class="close" onclick="this.parentElement.classList.add('hidden')"><i class="glyphicon glyphicon-remove"></i></div> <div class="popup-content" style="width: 25em;"> <form method="post" class="api-form" action="/a/login/?next=/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/"></form> </div> </div> <div id="subscription-popup" class="hidden popup"> <div class="close" onclick="this.parentElement.classList.add('hidden')"><i class="glyphicon glyphicon-remove"></i></div> <div id="subscription-popup-iframe" class="popup-content" style="width: 25em;"> </div> </div> <div id="scroll-top-pixel-anchor"></div> <button id="go-top" onclick="window.scrollTo({top: 20, left: 0, behavior: 'smooth'})">^</button> <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script> <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.4.1/js/bootstrap.min.js"></script> <script src="/static/js/main.df923d2272d3.js"></script> <script type="text/javascript"> if ( "IntersectionObserver" in window && "IntersectionObserverEntry" in window && "intersectionRatio" in window.IntersectionObserverEntry.prototype ) { let observer = new IntersectionObserver(entries => { if (entries[0].boundingClientRect.y < 0) { document.body.classList.add("scroll-top"); } else { document.body.classList.remove("scroll-top"); } }); observer.observe(document.getElementById("scroll-top-pixel-anchor")); } </script> </body> </html>

CINXE.COM

UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report